Data / Form D filings / Delfi Diagnostics, Inc.
Delfi Diagnostics, Inc.: Form D filings
Delfi Diagnostics, Inc., a biotechnology company in Palo Alto, CA, filed 5 Form D notices with the SEC between 2019 and 2025. The latest, on December 18, 2025, reports $34.3 million sold of a $60 million offering to 50 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1810 Embarcadero Road, Suite 100, Palo Alto, CA, 94303
- Phone
- (410) 961-9015
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1783735
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 18, 2025 | New notice | $60,000,000 | $34,333,315 | $25,666,685 | 50 | Dec 1, 2025 | sec.gov |
| Jul 25, 2022 | New notice | $224,999,876 | $224,999,876 | 44 | Jun 10, 2022 | sec.gov | |
| Jan 27, 2021 | New notice | $101,074,986 | $101,074,986 | 25 | Jan 12, 2021 | sec.gov | |
| Aug 27, 2019 | New notice | $5,500,000 | $5,500,000 | 7 | Aug 12, 2019 | sec.gov | |
| Aug 13, 2019 | New notice | $15,343 | $15,343 | 9 | Jun 18, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Peter B. Bach | Executive Officer | |
| Lee-Ann B. Smith-Freeman | Executive Officer | |
| Victor B. Velculescu | Director | |
| Susan Tousi | Executive Officer, Director | |
| Amoolya B. Singh | Executive Officer | |
| Elizabeth B. Homans | Director | |
| Rishi B. Gupta | Director | |
| Jacob B. Van Naarden | Director | |
| Michael B. Dybbs | Director | |
| Greg B. Yap | Director | |
| Justin B. Kao | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Dec 15, 2025 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Delfi Diagnostics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.